Vaccine Antigen Standardization
Vaccine Antigen Standardization - Related Videos
02:44
Western Blot for Assessing the Structural Integrity of a Bacterial Vaccine Antigen
0 Views •
2025
Source: Gilmore, S. F. et al. Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development. J. Vis. Exp. (2022)This video demonstrates the use of Western blotting to evaluate the structural integrity of the major outer membrane protein (MOMP) within nanoparticle-based vaccine complexes. It outlines the key steps involved in protein transfer, antibody labeling, and fluorescence imaging.
01:51
Vaccinations
0 Views •
2019
Overview Vaccination is the administration of antigenic material from pathogens to confer immunity against a specific microorganism. Vaccination primes the immune system to recognize and mount an immune response faster and more effectively if the real pathogen is encountered. Vaccinations are one of the most efficient ways to protect both individual humans and the general public from disease. A growing anti-vaccination skepticism risks the successes of vaccination programs that helped reduce...
07:05
In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model
0 Views •
Cited by 4 •
2017
The goal of this protocol is to allow for detection of in vivo antigen-specific killing of a target cell in a murine model.
11:07
Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
0 Views •
Cited by 14 •
2015
We describe whole-animal imaging and flow cytometry-based techniques for monitoring expansion of antigen-specific CD8+ T cells in response to immunization with nanoparticles in a murine model of vaccination.
13:36
Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
0 Views •
Cited by 1 •
2015
Here, we present a protocol to generate a proof-of-principle divalent adenovirus type 5 (Ad5) vector Ad5/H5-HVR1-KWAS-HVR5-His6 by utilizing the Antigen Capsid-Incorporation strategy. This vector was demonstrated to exhibit qualitative fitness, the capability to escape Ad5-positive sera in vitro, and the antigenicity as well as immunogenicity to the incorporated antigens.
FAQs
Reference standards provide a calibrated basis for analytical and potency assays, allowing measured antigen values to be interpreted against a consistent benchmark. This reduces dependence on assay-specific or batch-specific readings and supports meaningful comparisons among formulations, manufacturing lots, and research studies. As a result, observed differences are more likely to reflect the vaccine materials rather than inconsistent measurement systems.
These attributes describe different aspects of antigen quality and cannot be represented reliably by a single measurement. Identity confirms what antigen is present, amount indicates how much is present, purity addresses unwanted material, and biological activity shows whether the antigen retains relevant function. Considering all four dimensions gives quality control and dose evaluation a more complete scientific basis.
Immunochemical binding tests assess recognition of the antigen, while protein or nucleic acid measurements estimate its quantity. Functional potency assays instead examine a biological effect through an immune response. Using these approaches together helps distinguish the presence of an antigen from its measured amount and from its ability to support the intended immune-related activity.
Variation may arise between production lots, vaccine formulations, or stages of stability monitoring. Standardized measurements help identify whether antigen-related properties remain consistent or change over time. Detecting such differences supports manufacturing oversight and provides evidence for evaluating whether a product continues to meet established quality expectations rather than relying only on its intended composition.
A typical workflow establishes reference standards, calibrates analytical and potency assays against them, and then measures relevant antigen attributes in vaccine batches. The resulting values can be compared across lots and formulations, with identity, quantity, purity, and biological activity considered together. This organized comparison supports production monitoring, consistency assessment, and interpretation of later quality results.
Standardized antigen values allow investigators to compare vaccine formulations, production lots, and study results using a shared measurement basis. In immunology and infection research, this improves interpretation of immune-response findings and supports more consistent dose selection. The same information also contributes to quality control, regulatory evaluation, and assessment of vaccine safety and efficacy results.